EllenJKimMD(She/Her)

Professor of Dermatology, Penn Medicine

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Dept Dermatology, Perelman School of Medicine at Univ Pennsylvania
3400 Civic Center Blvd
Philadelphia, PA 19104
Phone+1 215-662-2737

Fax+1 215-615-4966

Dr. Ellen J. Kim is a board certified dermatologist and Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. She is currently the Director of the Penn Cutaneous Lymphoma Program/Photopheresis Service and Vice Chair of Clinical Operations for the Department of Dermatology. She is an international expert in the diagnosis and multidisciplinary clinical care of patients with cutaneous lymphomas and the use of extracorporeal photopheresis. Her primary research focus is clinical trials of novel therapies for cutaneous T-cell lymphoma (CTCL).

Leonard Berwick Memorial Teaching Award Perelman School of Medicine at the University of Pennsylvania, 2014
Inaugural Class, The Academy of Master Clinicians Penn Medicine, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FAAD) American Academy of Dermatology
Join now to see all

PubMed

1 citations
Cutaneous B-Cell Lymphomas.
Jennifer Villasenor-Park, Jina Chung, Ellen J Kim
Hematology/oncology Clinics of North America. 2024-10-01
1 citations
Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature.
Genevieve S Silva, Ellen J Kim, Stefan K Barta, Jina Chung
Expert Review of Anticancer Therapy. 2024-09-01
Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary ...
Simon J Gunter, Ellen J Kim
The Journal of Investigative Dermatology. 2024-04-01

Journal Articles

Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome
Paul L Haun, Sara S Samimi, Alain H Rook, Ellen J Kim, JAMA Dermatology
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome
Ellen J Kim, Carmela Vittorio, Paul L Haun, Sara S Samimi, Rachael A Clark, Alain H Rook, JAMA Dermatology

Lectures

Novel Therapies for Cutaneous Malignancies: What's New and What's Ahead
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-cell LymphomaDecember 16th, 2024
HyBryte™ Expanded Treatment Results to Be Presented at the European Organisation for Research and Treatment of Cancer ConferenceOctober 7th, 2024
New PDT Therapy for CTCL to Be Reviewed by FDADecember 22nd, 2022
Join now to see all